MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 22, Issue SUPPL. 2, 2012, Pages

  Forbes, Sean C ^a   Lott, Donovan J ^a   Finkel, Richard S ^b   Senesac, Claudia ^a   Byrne, Barry J ^a,c   Sweeney, H Lee ^d   Walter, Glenn A ^a   Vandenborne, Krista ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarker; Duchenne muscular dystrophy; Female carrier; Magnetic resonance imaging; Magnetic resonance spectroscopy; Skeletal muscle

Indexed keywords

ARTICLE; BODY COMPOSITION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CARRIER; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR DIGITORUM LONGUS MUSCLE; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GASTROCNEMIUS MUSCLE; GRACILIS MUSCLE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MOTOR PERFORMANCE; MUSCLE EXAMINATION; MUSCLE FUNCTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERONEUS MUSCLE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECTUS FEMORIS MUSCLE; SARTORIUS MUSCLE; SEMITENDINOUS MUSCLE; SOLEUS MUSCLE; TASK PERFORMANCE; TIBIALIS ANTERIOR MUSCLE; TIBIALIS POSTERIOR MUSCLE; VASTUS LATERALIS MUSCLE;

FEMALE; HUMANS; LIPIDS; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 84866285808     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.05.013     Document Type: Article

References (44)

1. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
2. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, Part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9:77-93.
3. Ceulemans B.P., Storm K., Reyniers E., Callewaert L., Martin J.J. Muscle pain as the only presenting symptom in a girl with dystrophinopathy. Pediatr Neurol 2008, 38:64-66.
4. Hoogerwaard E., Bakker E., Ippel P., et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study. Lancet 1999, 353:2116-2119.
5. Yilmaz A., Gdynia H.-J., Ludolph A.C., Klingel K., Kandolf R., Sechtem U. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation 2010, 121:e237-239.
6. Walcher T., Kunze M., Steinbach P., et al. Cardiac involvement in a female carrier of Duchenne muscular dystrophy. Int J Cardiol 2010, 138:302-305.
7. Moser H., Emery A. The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 1974, 5:271-284.
8. Song T.-J., Lee K.-A., Kang S.-W., Cho H., Choi Y.-C. Three cases of manifesting female carriers in patients with Duchenne muscular dystrophy. Yonsei Med J 2011, 52:192-195.
9. Boyd Y., Buckle V., Holt S., Munro E., Hunter D., Craig I. Muscular dystrophy in girls with X;autosomal translocations. J Med Genet 1986, 23:484-490.
10. Gualandi F., Brioschi S., Falzarano M.S., et al. Whole genetic and protein characterization in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing. Neuromuscul Disord 2011, D21:517.
11. Arahata K., Ishihara T., Kamakura K., et al. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med 1989, 19:138-142.
12. Griggs R.C., Mendell J.R., Brooke M.H., et al. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve 1985, 8:60-67.
13. Norman A., Harper P. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales. Clin Genet 1989, 36:31-37.
14. Grain L., Cortina-Borja M., Forfar C., Hilton-Jones D., Hopkin J., Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord 2001, 11:186-191.
15. Meola G., Scarpini E., Silani V., Scarlato G. Manifesting carrier of X-linked Duchenne muscular dystrophy. J Neurol Sci 1981, 49:455-463.
16. Yoon J., Kim S.H., Ki C.-S., et al. Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis. J Korean Med Sci 2011, 26:587-591.
17. Matsumura K., Nakano I., Fukuda N., Ikehira H., Tateno Y., Aoki Y. Duchenne muscular dystrophy carriers. Proton spin-lattice relaxation times of skeletal muscles on magnetic resonance imaging. Neuroradiology 1989, 31:373-376.
18. Wang L., Salibi N., Wu Y., Schweitzer M.E., Regatte R.R. Relaxation times of skeletal muscle metabolites at 7T. J Magn Reson Imaging 2009, 29:1457-1464.
19. Gold G.E., Han E., Stainsby J., Wright G., Brittain J., Beaulieu C. At 3.0T: relaxation times and image contrast. Am J Roentgenol 2004, 183:343-351.
20. Maier C.F., Tan S.G., Hariharan H., Potter H.G. T2 quantitation of articular cartilage at 1.5 T. J Magn Reson Imaging 2003, 17:358-364.
21. Elliott M.A., Walter G.A., Swift A., Vandenborne K., Schotland J.C., Leigh J.S. Spectral quantitation by principal component analysis using complex singular value decomposition. Magn Reson Med 1999, 41:450-455.
22. Whittall K.P., MacKay A.L. Quantitative interpretation of NMR relaxation data. J Magn Reson 1989, 84:134-152.
23. Zhao Q., Patriotis P., Arias-Mendoza F., Stoyanova R., Brown T.R. An interactive software for 3D chemical shift imaging data analysis and real time spectral localization and quantification. Proc Int Soc Mag Reson Med 2005, 13:2465.
24. Mathur S., Lott D.J., Senesac C., et al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2010, 91:1051-1058.
25. Brookes M.H., Griggs R.C., Mendell J.R., Fenichel G.M., Shumate J.B., Pellegrino R.J. Clinical trials in Duchenne dystrophy. I: The design of the protocol. Muscle Nerve 1981, 4:186-197.
26. Glover G.H., Schneider E. Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 1991, 18:371-383.
27. Wren T.A.L., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. Am J Roentgenol 2008, 190:W8-12.
28. Gloor M., Fasler S., Fischmann A., et al. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods. J Magn Reson Imaging 2011, 33:203-210.
29. Kan H.E., Scheenen T.W.J., Wohlgemuth M., et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009, 19:357-362.
30. Loganathan R., Bilgen M., Al-Hafez B., Smirnova I.R. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging 2005, 22:81-90.
31. Foley J.M., Yayaraman R.C., Prior B.M., Pivarnik J.M., Meyer R.A. MR measurements of muscle damage and adaptation after eccentric exercise. J Appl Physiol 1999, 87:2311-2318.
32. Mathur S., Vohra R.S., Germain S.A., et al. Changes in muscle T2 and tissue damage after downhill running in mdx Mice. Muscle Nerve 2011, 43:878-886.
33. 2 changes associated with single and repeated bouts of downhill running leading to eccentric-induced muscle damage. J Appl Physiol 2008, 105:299-307.
34. 2 relaxation in skeletal muscle. Magn Reson Med 1997, 37:676-682.
35. Marden F.A., Connolly A.M., Siegel M.J., Rubin D.A. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 2005, 34:140-148.
36. Akima H., Lott D., Senesac C., et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord 2012, 22(1):16-25.
37. Greeves J.P., Cable N.T., Reilly T., Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci 1999, 97:79-84.
38. Ditroilo M., Forte R., Benelli P., Gambarara D., De vito G. Effects of age and limb dominance on upper and lower limb muscle function in healthy males and females aged 40-80 years. J Sports Sci 2010, 28:667-677.
39. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985, 132:919-923.
40. Society A.T. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
41. McDonald C.M., Henricson E.K., Han J.J., et al. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve 2010, 42:966-974.
42. McDonald C.M., Henricson E.K., Han J.J., et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010, 41:500-510.
43. Kierkegaard M., Tollbäck A. Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord 2007, 17:943-949.
44. Enright P.L., Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998, 158:1384-1387.